Premium
Treatment of senile macular degeneration by laser photocoagulation
Author(s) -
Nielsen Niels Vesti,
FrostLarsen Kim,
Gregersen Eilif,
Scherfig Erik
Publication year - 1985
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1985.tb06860.x
Subject(s) - medicine , macular degeneration , ophthalmology , age related maculopathy , lesion , green laser , laser treatment , visual acuity , blindness , surgery , laser , retinopathy , optometry , maculopathy , optics , diabetes mellitus , physics , endocrinology
Abstract 117 eyes of 103 patients among 476 patients with senile macular degeneration fulfilled a criterion for treatment with blue‐green Argon (n = 20 eyes), green Argon (n = 15 eyes) Krypton‐red (n = 58 eyes) and combined treatment (24 eyes). In 50 consecutive treated eyes (= 50 patients) with an observation time exceeding one year a visual acuity 6/18 was preserved in 34 eyes. This post‐laser course differs from the spontaneous course of the disease reported in literature indicating that about 70% of eyes with perifoveal neovascular lesion will develop legal blindness within 2 years. Even though the spontaneous course in this material is unknown, and the comparability to patient material in literature is questionable, it might be concluded that a considerable part of the patients with senile macular degeneration with neovascular lesions might benefit from laser‐treatment.